Member Info for Num4

Once we have some concrete study findings published if this isn't in AGILE, it's a criminal offence to the world.

Bobbler, nice find. I'd not seen that previously - always a lull at the start of the year since still in recovery mode myself, haha.
With the positive human lung cell results already and John mentioning that this information will have been fed back to the government via the research team at UKRI then imo we should find out very soon of the intent to go into AGILE, there is no reason to delay it any longer.

I think for them to already report good initial findings is all the assurance we need. They tested it against human lung cells first to give that quick initial finding, now in a mouse again for the study to complete but we know it is safe in these preclinical tests so imo nothing to worry about with 1801 going into trials on COVID via AGILE.
I'd be surprised if a bigger player doesn't take that over though, with regards the comment on R&D collaboration on UKRI page, I thought they have it away initially aswell but I guess it is a collaboration between the very people who supply the funding, government.
Government are aware as John pointed out in the Q&A, only thing not to like about Sareum at present is the lack of cash in bank, but counter that with the amount of potential income streams over the next 2month and it's certainly an exciting time.

Always avoid the 1st hour of trading, don't panic and watch this now recover. Private investors may have just been robbed.

Just listen to Tim in that interview and relax. A deal is coming and it may well be early for 1801. Sierra conclusion also coming, out-license on the cards and he also talks about going back to SKIL or in-license to bolster the pipeline.

https://www.edisongroup.com/edison-tv/sareum-holdings-edison-open-house-interview/

That could be the nail on the head Big.

Yes, don't panic. Edison report is good but they didn't put a valuation out. Which if you look at other initiation reports they do.
I think they are cautious about putting the potential billions of value Sareum have in their compounds and fully patented.

It's PR from the company, something we have criticized them for a lack of.
They would obviously look at cash available and highlight the need this year.
It's whether we do it now or post COVID results. I personally think it will be before the POC to allow other long term investors in at a discount price before we enter the inflection point mentioned.
2p placing would be acceptable and we'll bounce straight back if we have funding for our own CTA through to completion.
We won't deal before CTA announced, it must go to CTA so the purchaser can't screw with it.

Interesting that other Edison Initiation research notes ascribes a value to the company. I wonder why they haven't gone down that route with Sareum.

That was a nice drop to get some buys in, the rollercoaster is getting ready and we have the queue jump tickets for the front seats!
Don't fall out after the first loop the loop. Sick buckets at the ready. Hahaha

Bill Gates

The interesting element will be the willingness of UK gov to invest in and buy the pills in advance. A very real possibility and lessons have already been learnt with regards to this strategy.
Nothing to stop a large government contract being in place upon a successful lab study.
This isn't like a mask, where they can get their mates the contracts, if it is proposed by UKRI then it's happening.
We need more dialogue on this from the bod at the next meeting.

Hahaha, several! Scatter cash at all the best "bars"

I'm even more confident of a 3p target by next week now. I managed to top up this morning, reported as a sell to contribute to the earlier topic on sells being buys, that information is correct as per Laz posts.
From memory Parker has the occasional tweet,but it's mostly retweet and no actual effort, this is the most bullish I've seen Parker.
As for interest, don't worry about that and enjoy the peace and genuine postings while we can, as mentioned this could change in the blink of an eye and the majority of people/investors don't look at a mcap, they'll just look at previous history with the COVID stocks. 2p to x, nothing is impossible here.
Good luck to all the genuine investors and newbies for.the coming weeks.

Hoping for a bit of meat on the Sareum tyk2 bone, looks like the target is already proven. All good signs for a positive outcome from our lab study.
https://www.sciencedaily.com/releases/2021/03/210310122514.htm

Hi Thoth, 8weeks can't come quick enough - if we have to wait that long. My only concern is that why haven't the other tyk2 players made their compounds available. If the research is right then BMS has the better compound in theory.
BMS have some data on their TYK2 out next week, 22nd I believe.

It actually gets better and I've not noticed this before. So the study is down as being a "Collaborative R&D" who exactly are we collaborating with as it certainly hasn't been announced. They are normally classified as a feasibility study.

I think you meant to post this Bobbler : https://gtr.ukri.org/projects?ref=83721

I know we've seen this article a few times, but to have our very own UKRI, who supplied our grant make the publication tells us that this is going further:
https://www.ukri.org/news/five-genes-identified-that-could-be-key-to-new-covid-19-treatments/

Then Dr. Kenneth Baillie, the chief investigator is quoted saying "Our results immediately highlight which drugs should be at the top of the list for clinical testing. We can only test a few drugs at a time, so making the right choices will save thousands of lives."

Therefore TYK2 is top of the list. Simples.